Compare Union Pacific Corporation (UNP) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Union Pacific Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? Union Pacific Corporation trades at $295.5 (market cap $175.89B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Union Pacific Corporation pays a 1.86% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| UNP | XBI | |
|---|---|---|
Market Cap | $175.89B | — |
Sector | Industrials | Broad Market / Factor |
52-Week High | $301.75 | $164.28 |
52-Week Low | $214.91 | $85.16 |
Enterprise Value | $206.36B | — |
Dividend Yield | 1.86% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.
Read more on UNP →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
